Blood Cell Clues Reveal Who Benefits When Radiotherapy Meets Immunotherapy in Lung Cancer
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
A phase II trial found that nanoparticle polymeric micellar paclitaxel combined with carboplatin and sintilimab produced an objective response rate ...
The first randomised trial comparing microwave ablation with stereotactic body radiotherapy for oligometastatic colorectal liver metastases found similar local control ...
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
An Ethiopian randomized trial found that a single session of thermotherapy achieved cure rates comparable to weekly intralesional sodium stibogluconate ...
A multicentre Phase II trial found that neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil before transoral surgery allowed 91 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine